NFKB1 and liver disorder: Since inhibition of NF-κB sensitizes hepatocytes to TNFα-induced cell death [37], it is important to determine the effect of metformin on NF-κB activation, prior to its use in inflammatory (TNFα-mediated) liver diseases.